prbd News

Press Releases for Antibodies

640

Musculoskeletal Disorders Therapeutics to 2016

The High Growth Rate and Increasing Use of Biologics Has Made the Musculoskeletal Disorders Therapeutics Market Attractive
By : | 09-20-2010 | Health and Fitness:Healthcare | Total Views : 640
854

Novus Biologicals Announce New Beta Amyloid Pyroglutamate Antibodies

Novus Biologicals, a leading international supplier of high quality antibodies and proteins to the bioresearch industry, is pleased to announce the introduction of a new range of Beta Amyloid antibodies to their antibody catalogue.
By : | 09-04-2010 | Health and Fitness:Health and Fitness | Total Views : 854
608

Manufacturing of Biologics

The Global Biologics Industry Has Grown More Rapidly Than the Global Pharmaceutical Industry
By : | 09-01-2010 | Health and Fitness:Healthcare | Total Views : 608
1390

Novus Biologicals Releases Two New Posters To Guide Antibody Research

Novus revealed two new posters at the ISSCR 8th Annual Meeting between June 16 - 19 - a fluorescent labels poster and a stem cell signalling pathway poster.
By : | 07-31-2010 | Science and Research:Science and Research | Total Views : 1390
733

Indian Therapeutic Monoclonal Antibodies Market to Grow at a CAGR of 27% during 2011-2016

The study, that has been undertaken using desk-based as well as qualitative primary market research provides and draws upon a comprehensive analysis of the Indian therapeutic monoclonal antibodies market.
By : | 03-15-2012 | Health and Fitness:Healthcare | Total Views : 733
670

Gain a Deep Insight into the Global Healthcare Cold Chain Logistic Services Market

Driven by a strong demand of biopharmaceuticals, vaccines and clinical trial materials; the global market for healthcare cold chain logistic services is expected to grow exponentially in the coming years.
By : | 03-12-2012 | Health and Fitness:Healthcare | Total Views : 670
1061

Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years

Driven by factors such as increasing popularity in preliminary testing, portability and ease of use; the market for Immunodiagnostics is expected to grow robustly in the coming years.
By : | 02-06-2012 | Medical:Medical | Total Views : 1061
709

Most of the Marketed Monoclonal Antibodies Lack a Patent Protection in India

Biosimilar manufacturers are currently free to copy and manufacture most of the globally marketed therapeutic monoclonal antibodies in India.
By : | 01-24-2012 | Health and Fitness:Health and Fitness | Total Views : 709
630

IMARC Releases the Most Robust Analysis on the Indian Diagnostic & Therapeutic Antibodies Market

A new report from IMARC Group finds that the Indian market for both diagnostic and therapeutic antibodies is expected to grow exponentially in the coming years.
By : | 01-16-2012 | Business:Business | Total Views : 630
766

Biosimilar/Follow-on Monoclonal Antibodies: The Next Big Thing for Generic Manufacturers

With the patents of all major monoclonal antibodies set to expire during 2015 - 2020, Biosimilar (or Follow-on) Monoclonal Antibodies are expected to represent the next big thing for generic manufacturers.
By : | 11-02-2011 | Medical:Medical | Total Views : 766

Page 1 of 2

1 | 2

TOP 10 PR Updates